News
Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...
Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...
New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...
For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can naturally mimic the effects of semaglutides.
Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.
Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results